Brain and Spine, 2022
Cerebrospinal fluid and peripheral blood proteomics in Traumatic Spinal Cord Injury: A prospective pilot study

Wichmann T., Kasch H., Dyrskog S. et al.

Journal of Neuroendocrinology, 2022
Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors

Thiis‐Evensen E., Kjellman M., Knigge U. et al.

International Journal of Cardiology, 2022
Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study)

de Lange I., Petersen T., de Bakker M. et al.

Brain Communications, 2022
Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment

Kivisäkk P., Magdamo C., Trombetta B. et al.

Scientific Reports, 2022
Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis

Pallares Robles A., ten Cate V., Schulz A. et al.

Nature Biotechnology, 2022
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR

Schwarz M., Torre D., Lozano-Ojalvo D. et al.

Molecular Psychiatry, 2022
Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study

Sandberg J., Hansson C., Göteson A. et al.

British Journal of Haematology, 2022
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease

Pratta M., Paczesny S., Socie G. et al.

Scientific Reports, 2022
Targeted proteomics of appendicular skeletal muscle mass and handgrip strength in black South Africans: a cross-sectional study

Dlamini S., Norris S., Mendham A. et al.

European Journal of Endocrinology, 2022
Novel inflammatory biomarkers in thyroid eye disease

Ueland H., Ueland G., Løvås K. et al.

Arthritis & Rheumatology, 2022
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel

Loza M., Nagpal S., Cole S. et al.

Nature Communications, 2022
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

Damsky W., Wang A., Kim D. et al.

Communications Biology, 2022
Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort

Yang J., Jia Z., Song X. et al.

Frontiers in Neurology, 2022
Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease

Carlyle B., Kitchen R., Mattingly Z. et al.

Nature Medicine, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Padrón L., Maurer D., O’Hara M. et al.

BMC Women's Health, 2022
Applicability of polygenic risk scores in endometriosis clinical presentation

Svensson A., Garcia-Etxebarria K., Åkesson A. et al.

Brain, 2022
A Mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease

Bottigliengo D., Foco L., Seibler P. et al.

Kidney Medicine, 2022
Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay

Schmidt I., Colona M., Srivastava A. et al.

Scandinavian Journal of Immunology, 2022
The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes

Ljunggren H., Heggernes Ask E., Cornillet M. et al.

Nature Communications, 2022
Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Liu J., Wang Y., Tian Z. et al.